SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: These findings emphasize the importance of comprehensive genetic testing beyond SCN1A, providing valuable insights for personalized management and tailored therapeutic interventions in patients with Dravet syndrome.